US Patent Issued to Paragon Therapeutics on Nov. 11 for "TL1A binding proteins and methods of use" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,890, issued on Nov. 11, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.).

"TL1A binding proteins and methods of use" was invented by Eric Franklin Zhu (Cambridge, Mass.), Hussam Hisham Shaheen (Auburn, N.H.) and Daniel Rios (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are TL1A binding proteins (e.g., antibodies that bind TL1A) and methods of use."

The patent was filed on Dec. 30, 2024, under Application No. 19/005,529.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=...